Role of hysteroscopy during conservative management of atypical endometrial hyperplasia and early-stage endometrial cancer in patients who desire pregnancy

References

• Atallah, D., et al., 2021. The use of hysteroscopic endometrectomy in the conservative treatment of early endometrial cancer and atypical hyperplasia in fertile women. Archives of Gynecology and Obstetrics, 304 (5), 1299–1305.
   PubMed Web of Science ®Google Scholar
• Casadio, P., et al., 2020. Fertility sparing treatment of endometrial cancer with and without initial infiltration of myometrium: a single center experience. Cancers, 12 (12), 3571.
   PubMed Web of Science ®Google Scholar
• Di Spiezio Sardo, A., et al., 2020. Should endometrial biopsy under direct hysteroscopic visualization using the grasp technique become the new gold standard for the preoperative evaluation of the patient with endometrial cancer? Gynecologic Oncology, 158 (2), 347–353.
   PubMed Web of Science ®Google Scholar
• Di Spiezio Sardo, A., Saccone, G., and Carugno, J., 2022. Endometrial biopsy under direct hysteroscopic visualisation versus blind endometrial sampling for the diagnosis of endometrial hyperplasia and cancer: systematic review and meta-analysis. Facts, Views & Vision in Obgyn, 14 (2), 103–110.
   PubMed Web of Science ®Google Scholar
• Falcone, F., et al., 2017. Fertility preserving treatment with hysteroscopic resection followed by progestin therapy in young women with early endometrial cancer. Journal of Gynecologic Oncology, 28 (1), e2.
   PubMed Web of Science ®Google Scholar
• Feichtinger, M. and Rodriguez-Wallberg, K.A., 2016. Fertility preservation in women with cervical, endometrial or ovarian cancers. Gynecologic Oncology Research and Practice, 3, 8.
   PubMedGoogle Scholar
• Gallos, I.D., et al., 2010. Oral progestogens vs levonorgestrel-releasing intrauterine system for endometrial hyperplasia: a systematic review and metaanalysis. American Journal of Obstetrics and Gynecology, 203, 547.e1–547.e10.
   PubMed Web of Science ®Google Scholar
• Gallos, I.D., et al., 2012. Regression, relapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia: a systematic review and metaanalysis. American Journal of Obstetrics and Gynecology, 207 (4), 266.e1–266.e12.
   PubMed Web of Science ®Google Scholar
• Giampaolino, P., et al., 2019. Hysteroscopic endometrial focal resection followed by levonorgestrel intrauterine device insertion as a fertility-sparing treatment of atypical endometrial hyperplasia and early endometrial cancer: a retrospective study. Journal of Minimally Invasive Gynecology, 26 (4), 648–656.
   PubMed Web of Science ®Google Scholar
• Gotlieb, W.H., et al., 2003. Outcome of fertility-sparing treatment with progestins in young patients with endometrial cancer. Obstetrics and Gynecology, 102 (4), 718–725.
   PubMed Web of Science ®Google Scholar
• Guillon, S., et al., 2019. A systematic review and meta-analysis of prognostic factors for remission in fertility-sparing management of endometrial atypical hyperplasia and adenocarcinoma. International Journal of Gynaecology and Obstetrics, 146 (3), 277–288.
   PubMed Web of Science ®Google Scholar
• Gunderson, C.C., et al., 2012. Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma: a systematic review. Gynecologic Oncology, 125, 477–482.
   PubMed Web of Science ®Google Scholar
• Kurman, R.J., et al., 2014. WHO classification of tumours of female reproductive organs. IARC: Lyon.
   Google Scholar
• La Rosa, V.L., et al., 2020. Fertility preservation in women affected by gynaecological cancer: the importance of an integrated gynaecological and psychological approach. Ecancermedicalscience, 14, 1035.
   PubMed Web of Science ®Google Scholar
• Lee, T.S., et al., 2011. Management of endometrial hyperplasia with a levonorgestrel-releasing intrauterine system: single arm, prospective multicenter study: Korean Gynecologic Oncology Group Study (KGOG2006). Japanese Journal of Clinical Oncology, 41 (6), 817–819.
   PubMed Web of Science ®Google Scholar
• Lucchini, S.M., et al., 2021. Updates on conservative management of endometrial cancer in patients younger than 45 years. Gynecologic Oncology, 161 (3), 802–809.
   PubMed Web of Science ®Google Scholar
• Luo, L., et al., 2018. Oral and intrauterine progestogens for atypical endometrial hyperplasia. Cochrane Database of Systematic Reviews, 2008 (12), CD009458.
   Google Scholar
• Martínez Castro, P.L., et al., 2008. ¿Hiperplasia endometrial atípica o adenocarcinoma de endometrio? Un reto. Progresos de Obstetricia y Ginecología, 51 (10), 605–609.
   Google Scholar
• Mazzon, I., et al., 2005. Reproductive preservation for treatment of stage IA endometrial cancer in a young woman: hysteroscopic resection. International Journal of Gynecological Cancer, 15 (5), 974–978.
   PubMed Web of Science ®Google Scholar
• Mazzon, I., et al., 2010. Conservative surgical management of stage IA endometrial carcinoma for fertility preservation. Fertility and Sterility, 93 (4), 1286–1289.
   PubMed Web of Science ®Google Scholar
• Obermair, A., et al., 2020. Fertility-sparing treatment in early endometrial cancer: current state and future strategies. Obstetrics & Gynecology Science, 63 (4), 417–431.
   PubMedGoogle Scholar
• Pal, N., et al., 2018. Treatment of low-risk endometrial cancer and complex atypical hyperplasia with the levonorgestrel-releasing intrauterine device. Obstetrics and Gynecology, 131 (1), 109–116.
   PubMed Web of Science ®Google Scholar
• Raffone, A., et al., 2021. Clinical predictive factors of response to treatment in patients undergoing conservative management of atypical endometrial hyperplasia and early endometrial cancer. Journal of Adolescent and Young Adult Oncology, 10 (2), 193–201.
   PubMed Web of Science ®Google Scholar
• De Franciscis, P., et al., 2019. Concordance between the hysteroscopic diagnosis of endometrial hyperplasia and histopathological examination. Diagnostics, 9 (4), 142.
   Web of Science ®Google Scholar
• [RCOG] Royal College of Obstetricians and Gynaecologists (RCOG) with the British Society for Gynaecological Endoscopy (BSGE), 2016. Management of endometrial hyperplasia. Green-top guideline no. 67. RCOG/BSGE joint guideline. London: RCOG/BSGE.
   Google Scholar
• [RCOG] Royal College of Obstetricians and Gynaecologists, 2013. Fertility sparing treatment in gynaecological treatment. Scientific impact paper no. 35. London: RCOG.
   Google Scholar
• Tomao, F., et al., 2016. Special issues in fertility preservation for gynecologic malignancies. Critical Reviews in Oncology/Hematology, 97, 206–219.
   PubMed Web of Science ®Google Scholar
• Wei, J., et al., 2017. Comparison of fertility-sparing treatments in patients with early endometrial cancer and atypical complex hyperplasia: a meta-analysis and systematic review. Medicine, 96 (37), e8034.
   PubMed Web of Science ®Google Scholar
• Westin, S.N., et al., 2020. Prospective phase II trial of levonorgestrel intrauterine device: nonsurgical approach for complex atypical hyperplasia and early-stage endometrial cancer. American Journal of Obstetrics and Gynecology, 224, 191.e1–191.e15.
   PubMed Web of Science ®Google Scholar